Viewing Study NCT00466466


Ignite Creation Date: 2025-12-24 @ 4:15 PM
Ignite Modification Date: 2026-01-02 @ 2:44 AM
Study NCT ID: NCT00466466
Status: COMPLETED
Last Update Posted: 2020-12-21
First Post: 2007-04-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety of RAD001 in Combination With Cisplatin and Etoposide in Lung Cancer Patients
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module